Hunan Fangsheng Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603998.SS

Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2023: 11.00

Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio is 11.00 for the year ending December 31, 2023, a -29.08% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was 15.52, a 191.72% change year over year.
Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2021 was 5.32, a 16.91% change year over year.
Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2020 was 4.55, a -56.91% change year over year.
Hunan Fangsheng Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2019 was 10.56, a -40.30% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shanghai Stock Exchange: 603998.SS

Hunan Fangsheng Pharmaceutical Co., Ltd.

CEO	Ms. Xiaoli Zhou
IPO Date	Dec. 5, 2014
Location	China
Headquarters	No. 299, Jiayun Road
Employees	1,686
Sector	Health Care
Industries Pharmaceuticals

Description

Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in Changsha, China.

Key trends

Past 5 years